Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02351934 · ClinicalTrials.gov registry record · Phase 4
Early Diuresis Following Colorectal Surgery
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 123
- Enrollment target
NCT02351934: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT02351934 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 123 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02351934, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 123 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if giving a medicine called furosemide, which is a diuretic or water pill, after colon surgery will safely shorten the patient's length of hospital stay.
Interventions
- DRUG Celecoxib
- DRUG Furosemide
- DRUG Gabapentin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2015-02 |
| Est. Completion | 2016-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02351934
The ClinicalTrials.gov registry entry for NCT02351934 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Celecoxib is the first listed.
NCT02351934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02351934 about?
NCT02351934 is a clinical study titled "Early Diuresis Following Colorectal Surgery". The purpose of this study is to find out if giving a medicine called furosemide, which is a diuretic or water pill, after colon surgery will safely shorten the patient's length of hospital stay.
What is the current status of trial NCT02351934?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 123 participants. The study started on 2015-02. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02351934?
The interventions under investigation include: Celecoxib (DRUG), Furosemide (DRUG), Gabapentin (DRUG).
Who is sponsoring clinical trial NCT02351934?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.